Derek Hicks
Corporate Officer/Principal bij INTELLIA THERAPEUTICS, INC.
Vermogen: 1 M $ op 30-04-2024
Actieve functies van Derek Hicks
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Corporate Officer/Principal | 20-12-2021 | - |
Loopbaan van Derek Hicks
Eerdere bekende functies van Derek Hicks
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01-09-2020 | 01-12-2021 |
Opleiding van Derek Hicks
| University of Connecticut | Graduate Degree |
| Kelley School of Business | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
- Beurs
- Insiders
- Derek Hicks
- Ervaring
